NASDAQ$ALHC
Alignment Healthcare Inc · Q3 2023 earnings
Q3 2023 earnings · · Investor relations
Briefing
Reported exceeding guidance across all key financial metrics.
Alignment Healthcare reported its Q3 2023 financial results, demonstrating strong performance and exceeding expectations across all key financial metrics. The company's success is attributed to its focus on service, quality, and advocacy in Medicare Advantage.
- Alignment Healthcare's third quarter results indicate a strong performance in Medicare Advantage.
- The company's largest MA contract has achieved at least 4- out of 5-stars for seven consecutive years.
- Alignment Health is championing a new path in senior care that empowers members to age well and live their most vibrant lives.
- Alignment Health offers more than 40 benefits-rich, value-driven Medicare Advantage plans that serve 52 counties across six states.
Headline financials
Revenue & EPS history
Alignment Healthcare · Revenue · Quarterly
$457M
Revenue by segment
Alignment Healthcare · $265M total across 2 segments · Q1 2021
- Earned premiums$265M+18.0%100.0%
- Other revenue$82K—0.0%
Forward guidance
The company provided an outlook for the fourth quarter and fiscal year 2023, but specific details were not included in the provided text.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q3 2023
+1.8%
Avg return
Earnings day
+1.8%
Avg return
5 days after
+2.6%
Avg return
30 days after
57%
12 / 21 earnings
Positive
+27.0%
Q1 2024
Best reaction
-16.4%
Q4 2022
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +3.8% | -15.7% | -29.5% | |
| Q4 2025 | -5.8% | -7.5% | -18.6% | |
| Q3 2025 | -1.9% | -0.4% | +12.2% | |
| Q1 2025 | -7.7% | -7.5% | -8.3% | |
| Q4 2024 | +16.5% | +17.4% | +35.9% | |
| Q3 2024 | +1.6% | +12.2% | +11.2% | |
| Q2 2024 | +2.3% | +4.9% | +3.1% | |
| Q1 2024 | +27.0% | +31.6% | +51.0% | |
| Q4 2023 | -8.9% | -9.2% | -20.1% | |
| Q3 2023 | -9.6% | -7.2% | +10.5% | |
| Q2 2023 | +7.5% | +10.5% | -4.2% | |
| Q1 2023 | +3.5% | +11.3% | -5.1% | |
| Q4 2022 | -16.4% | -20.9% | -35.2% | |
| Q3 2022 | -3.1% | -3.3% | -2.7% | |
| Q2 2022 | +10.4% | +4.3% | -8.7% | |
| Q1 2022 | -7.0% | -18.8% | +6.8% | |
| Q4 2021 | +10.7% | +8.0% | +39.7% | |
| Q3 2021 | +10.6% | +6.1% | -26.7% | |
| Q2 2021 | -8.5% | -4.8% | -11.2% | |
| Q1 2021 | +6.8% | +13.3% | +27.6% | |
| Q4 2020 | +6.8% | +13.3% | +27.6% | |
| Q3 2020 | — | — | — | |
| Q2 2020 | — | — | — | |
| Q1 2020 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro